{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:33:48Z","timestamp":1758274428602,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bulcan.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T14:35:03Z","timestamp":1679754903000},"page":"581-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumeurs rares\u00a0: angiosarcome"],"prefix":"10.1016","volume":"110","author":[{"given":"Nathan","family":"El-Ghazzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bulcan.2023.03.002_bib0300","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2023.03.002_bib0305","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and outcome of 82\u00a0patients with angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.002_bib0310","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"issue":"9","key":"10.1016\/j.bulcan.2023.03.002_bib0315","first-page":"693","article-title":"[Characteristics and outcomes of primary angiosarcoma]","volume":"41","author":"Zhang","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.002_bib0320","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2019.07.024","article-title":"Incidence and outcomes of cutaneous angiosarcoma: a SEER population-based study","volume":"83","author":"Conic","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.03.002_bib0325","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.bulcan.2023.03.002_bib0330","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.pas.0000156664.04955.83","article-title":"Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42\u00a0cases","volume":"29","author":"Brenn","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K","article-title":"Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma","volume":"92","author":"Huang","year":"2001","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.bulcan.2023.03.002_bib0340","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1002\/cncr.24462","article-title":"Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival","volume":"115","author":"Mery","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0345","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12885-017-3292-7","article-title":"Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study","volume":"17","author":"Yin","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.002_bib0350","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/medicina57040329","article-title":"Angiosarcoma of the urinary bladder following radiotherapy: report of a case and review of the literature","volume":"57","author":"Cito","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.32074\/1591-951X-3-20","article-title":"Primary post-radiation angiosarcoma of the small bowel. Report of a case and review of the literature","volume":"112","author":"Squillaci","year":"2020","journal-title":"Pathologica"},{"issue":"3\u00a0Suppl 1","key":"10.1016\/j.bulcan.2023.03.002_bib0360","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/abd1806-4841.20153685","article-title":"Stewart Treves Syndrome","volume":"90","author":"Pereira","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.bulcan.2023.03.002_bib0365","first-page":"229","article-title":"[Two cases of Stewart-Treves syndrome observed at Sanshu hospital]","volume":"37","author":"Yokoyama","year":"2010","journal-title":"Gan To Kagaku Ryoho"},{"issue":"5","key":"10.1016\/j.bulcan.2023.03.002_bib0370","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00008469-200310000-00012","article-title":"Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature","volume":"12","author":"Bosetti","year":"2003","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004032-200307000-00011","article-title":"Cancer risks from medical radiation","volume":"85","author":"Ron","year":"2003","journal-title":"Health Phys"},{"issue":"9","key":"10.1016\/j.bulcan.2023.03.002_bib0380","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ejso.2015.04.022","article-title":"Primary hepatic angiosarcoma","volume":"41","author":"Chaudhary","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00005792-197901000-00003","article-title":"The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature","volume":"58","author":"Locker","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bulcan.2023.03.002_bib0390","first-page":"57","article-title":"Life history and histopathology of ultraviolet light-induced skin tumors","volume":"50","author":"Stenb\u00e4ck","year":"1978","journal-title":"Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.002_bib0395","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/ajcp\/97.3.416","article-title":"Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis","volume":"97","author":"Ben-Izhak","year":"1992","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0400","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0741-5214(91)90158-Q","article-title":"Angiosarcoma at the site of a Dacron vascular prosthesis: a case report and literature review","volume":"14","author":"Weiss","year":"1991","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.bulcan.2023.03.002_bib0405","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/lrb.2018.0049","article-title":"Cancer risk in Klippel-Trenaunay syndrome","volume":"17","author":"Blatt","year":"2019","journal-title":"Lymphat Res Biol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.002_bib0410","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.jaad.2013.03.011","article-title":"Angiosarcoma in patients with xeroderma pigmentosum: less aggressive and not so rare?","volume":"69","author":"Karkouche","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.bulcan.2023.03.002_bib0415","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clbc.2015.06.011","article-title":"Early occurrence of angiosarcoma in a woman with a BRCA2\u00a0gene variation of unknown significance treated with breast-conserving therapy for bilateral ductal carcinoma: a case report","volume":"15","author":"Parvez","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2023.03.002_bib0420","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3816\/CBC.2008.n.066","article-title":"BRCA mutations and the risk of angiosarcoma after breast cancer treatment","volume":"8","author":"West","year":"2008","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.002_bib0425","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1479-666X(09)80094-2","article-title":"Cutaneous angiosarcoma after breast conserving treatment for bilateral breast cancers in a BRCA-1\u00a0gene mutation carrier\u00a0\u2013\u00a0a case report and review of the literature","volume":"7","author":"Williams","year":"2009","journal-title":"Surgeon"},{"issue":"8","key":"10.1016\/j.bulcan.2023.03.002_bib0430","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2023.03.002_bib0435","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1245\/s10434-009-0569-3","article-title":"Outcome of locally recurrent and metastatic angiosarcoma","volume":"16","author":"Lahat","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"1075","key":"10.1016\/j.bulcan.2023.03.002_bib0440","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170039","article-title":"Angiosarcoma: clinical and imaging features from head to toe","volume":"90","author":"Gaballah","year":"2017","journal-title":"Br J Radiol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.03.002_bib0445","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","article-title":"Cutaneous angiosarcoma: a current update","volume":"70","author":"Shustef","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bulcan.2023.03.002_bib0450","doi-asserted-by":"crossref","first-page":"798403","DOI":"10.1155\/2013\/798403","article-title":"Sporadic versus radiation-associated angiosarcoma: a comparative clinicopathologic and molecular analysis of 48\u00a0cases","volume":"2013","author":"Hung","year":"2013","journal-title":"Sarcoma"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/gcc.20827","article-title":"and FLT4\u00a0gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions","volume":"50","author":"Guo","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.002_bib0460","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1\u00a0mutations in angiosarcoma","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0465","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41591-019-0749-z","article-title":"The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research","volume":"26","author":"Painter","year":"2020","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.bulcan.2023.03.002_bib0470","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1172\/JCI139080","article-title":"Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma","volume":"130","author":"Chan","year":"2020","journal-title":"J Clin Invest"},{"issue":"16_suppl","key":"10.1016\/j.bulcan.2023.03.002_bib0475","doi-asserted-by":"crossref","first-page":"11572","DOI":"10.1200\/JCO.2022.40.16_suppl.11572","article-title":"Which angiosarcoma subtypes may benefit from immunotherapy?","volume":"40","author":"van\u00a0Ravensteijn","year":"2022","journal-title":"JCO"},{"issue":"11","key":"10.1016\/j.bulcan.2023.03.002_bib0480","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z","article-title":"Angiosarcoma. A report of 67\u00a0patients and a review of the literature","volume":"77","author":"Mark","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0485","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejca.2012.08.016","article-title":"Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF\/GETO)","volume":"49","author":"Lindet","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0b013e3180f633a3","article-title":"Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69\u00a0cases","volume":"32","author":"Deyrup","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.03.002_bib0495","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","article-title":"Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161\u00a0cases","volume":"18","author":"Fayette","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.002_bib0500","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.suronc.2018.07.010","article-title":"The importance of surgery in scalp angiosarcomas","volume":"27","author":"Cassidy","year":"2018","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0505","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2010.10.007","article-title":"Angiosarcoma: state of the art and perspectives","volume":"80","author":"Penel","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bulcan.2023.03.002_bib0510","unstructured":"Radiation-induced angiosarcoma of the breast: A review \u2013\u00a0Bonito\u00a0\u2013 2020 \u2013\u00a0The Breast Journal\u00a0\u2013 Wiley Online Library [Internet]. [cit\u00e9 30\u00a0mars 2022]. Disponible sur\u00a0: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/tbj.13504."},{"issue":"4","key":"10.1016\/j.bulcan.2023.03.002_bib0515","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoto.2014.3584","article-title":"Angiosarcoma of the scalp and face: the Mayo Clinic experience","volume":"141","author":"Patel","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"18","key":"10.1016\/j.bulcan.2023.03.002_bib0520","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.ejca.2014.10.004","article-title":"First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials","volume":"50","author":"Young","year":"2014","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.bulcan.2023.03.002_bib0525","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P","article-title":"Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face","volume":"86","author":"Fata","year":"1999","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.bulcan.2023.03.002_bib0530","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2008.07.037","article-title":"Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group","volume":"44","author":"Schlemmer","year":"2008","journal-title":"Eur J Cancer"},{"issue":"32","key":"10.1016\/j.bulcan.2023.03.002_bib0535","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0540","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdr138","article-title":"Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome","volume":"23","author":"Penel","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0545","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.bulcan.2023.03.002_bib0550","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2015.60.8505","article-title":"Paclitaxel Given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II trial","volume":"33","author":"Ray-Coquard","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0555","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1634\/theoncologist.2011-0237","article-title":"Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF\/GETO)","volume":"17","author":"Ray-Coquard","year":"2012","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bulcan.2023.03.002_bib0560","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11523-013-0299-0","article-title":"Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial","volume":"9","author":"Penel","year":"2014","journal-title":"Target Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0565","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","article-title":"Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis","volume":"56","author":"Koll\u00e1r","year":"2017","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.03.002_bib0570","doi-asserted-by":"crossref","first-page":"499","DOI":"10.6004\/jnccn.2016.0058","article-title":"Antitumor response of VEGFR2- and VEGFR3-amplified angiosarcoma to pazopanib","volume":"14","author":"Ravi","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.bulcan.2023.03.002_bib0575","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/annonc\/mdr066","article-title":"Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network","volume":"23","author":"Stacchiotti","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.03.002_bib0580","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s40425-019-0689-7","article-title":"Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution","volume":"7","author":"Florou","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"8","key":"10.1016\/j.bulcan.2023.03.002_bib0585","doi-asserted-by":"crossref","first-page":"e002990","DOI":"10.1136\/jitc-2021-002990","article-title":"Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4\u00a0and anti-PD-1\u00a0blockade in rare tumors (DART)","volume":"9","author":"Wagner","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2023.03.002_bib0295","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s00432-021-03678-4","article-title":"PARP inhibition in UV-associated angiosarcoma preclinical models","volume":"147","author":"Weidema","year":"2021","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:37:01Z","timestamp":1757792221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0007455123001406"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.03.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumeurs rares\u00a0: angiosarcome","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}